ArticleOrphanet journal of rare diseases2024

Real-world multidisciplinary outcomes of onasemnogene abeparvovec monotherapy in patients with spinal muscular atrophy type 1: experience of the French cohort in the first three years of treatment.

Isabelle Desguerre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.